Asia Pacific Sequencing Reagents Market

Market Introduction

Sequencing reagents are used during the process of sequencing. The use of these reagents highly depends on the desired result to be obtained. They form an essential part of the sequencing reactions, which can be used across various other applications as well. 

Asia Pacific Sequencing Reagents Strategic Insights

Strategic insights for the Asia Pacific Sequencing Reagents provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

Asia Pacific Sequencing Reagents Report Scope

Asia Pacific Sequencing Reagents Regional Insights

The geographic scope of the Asia Pacific Sequencing Reagents refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.

The Asia Pacific sequencing reagents market is expected to reach US$ 3,330.10 million by 2028 from US$ 1,392.13 million in 2021; it is estimated to grow at a CAGR of 13.3% from 2021 to 2028. The growth of the market is attributed to the increasing demand for third generation sequencing and personalized medicines. However, the dearth of skilled professionals hinders the market growth.

Genomic sequencing technologies have revolutionized mutation detection of the genetic diseases in the past few years. In recent years, the third-generation sequencing (TGS) has been gaining insight into more genetic diseases, owing to the single molecular and real time sequencing technology. One of these new technologies was developed by Pacific Biosciences and is called Single-Molecule Sequencing in Real Time (SMRT). SMRT is very efficient, which means that fewer expensive chemicals must be used. It is also incredibly sensitive, enabling scientists to effectively ‘eavesdrop’ on DNA polymerase and observe it making a strand of DNA. A rise in the demand for third-generation sequencing (TGS) technologies is attributive to the lucrative growth rate of this segment. With the emergence of TGS, genome sequencing has become a faster and reliable method to study genomic variations. Also, personalized medicine offers the most promising approaches to tackle diseases, which have far eluded effective treatments or cures. Increasing adoption of personalized medicines for disease treatments using the patient’s genetic information is expected to aid in offering targeted treatment. This, in turn, is expected to create lucrative growth opportunities for the sequencing reagent market during the forecast period.

Asia Pacific is adversely affected by COVID-19 pandemic. The genomics helped understand SARS-CoV-2, which enabled governments and researchers to track the emergence of COVID-19 outbreaks in their country. Healthcare experts realized the importance of genomics in the treatment of COVID-19, which is expected to raise the demand for genomic during the forecast period. Hence, the rising research activities on the novel coronavirus that causes COVID-19 are paving a way for potential opportunities for start-ups and established businesses. For instance, Haystack Analytics, a start-up company in Mumbai, India, is using genomics to study the transmission of the coronavirus to help the Indian government. Thus, the demand for genomics is increasing due to the rising cases of COVID-19. As a result, the need for sequencing reagents is growing, which is driving the growth of the market.

Key Market Segments

The Asia Pacific sequencing reagents market, by technology, is segmented into next generation sequencing, sanger sequencing, and third generation sequencing. The next generation sequencing segment held the largest share of the market in 2020. However, the sanger sequencing segment is anticipated to register the highest CAGR in the market during the forecast period.

The Asia Pacific sequencing reagents market, by reagent type, is segmented into control kits, library kits, template kits, sequencing kits, and other reagent types. The sequencing kits segment held the largest share of the market in 2020, whereas the library kits segment is anticipated to register the highest CAGR in the market during the forecast period.

The Asia Pacific sequencing reagents market, by application, is segmented into agrigenomics and forensics, clinical investigation, oncology, reproductive health, and other applications. The oncology segment held the largest share of the market in 2020. However, the clinical investigation segment is anticipated to register the highest CAGR in the market during the forecast period.

Major Sources and Companies Listed

A few of the primary and secondary sources associated with this report on the Asia Pacific sequencing reagents market are Japan Agency for Medical Research and Development (AMED), Genomics Health Futures Mission and World Health Organization (WHO).

Reasons to buy the report

• Determine prospective investment areas based on a detailed trend analysis of Asia Pacific sequencing reagents market over the next years.
• Gain an in-depth understanding of the underlying factors driving demand for different addictions therapeutics segments in the top spending countries and identify the opportunities offered by each of them.
• Strengthen your knowledge of the market in terms of demand drivers, industry trends, and the latest technological developments, among others.
• Identify the major channels driving the Asia Pacific sequencing reagents market, providing a clear picture of future opportunities that will help analyze, resulting in revenue expansion.
• Channelize resources by focusing on the ongoing programs undertaken by the different countries within the Asia Pacific sequencing reagents market.

ASIA PACIFIC SEQUENCING REAGENTS MARKET SEGMENTATION

By Technology

• Next Generation Sequencing
• Sanger Sequencing
• Third Generation Sequencing

By Reagent Type

• Control Kits
• Library Kits
• Template Kits
• Sequencing Kits
• Other Reagent Types

By Application

• Agri genomics and Forensics
• Clinical Investigation
• Oncology
• Reproductive Health
• Other Applications

By End User   

• Hospitals and Clinics
• Research Institutes
• Pharmaceutical and Biotechnology Companies
• Other End Users

By Country

• China
• Japan
• India
• Australia
• South Korea
• Rest of Asia Pacific

Company Profiles

• Pacific Biosciences of California, Inc.
• QIAGEN
• Takara Bio Inc.
• THERMO FISHER SCIENTIFIC INC.
• TriLink BioTechnologies Inc
• BGI
• F. HOFFMANN-LA ROCHE LTD.
• Illumina, Inc.
• FLUIDIGM CORPORATION
• LGC Biosearch Technologies